Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion.

[1]  M. Horsman,et al.  Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. , 1991, British Journal of Cancer.

[2]  J. R. Griffiths,et al.  Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. , 1990, British Journal of Cancer.

[3]  V. R. McCready,et al.  The effects of single dose oral hydralazine on blood flow through human lung tumours. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  J. Gavin,et al.  The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels. , 1990, British Journal of Cancer.

[5]  J. Overgaard,et al.  The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  P. Okunieff,et al.  Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSall tumors. , 1990, Cancer research.

[7]  J. Overgaard,et al.  Invasive blood pressure measurements in restrained but non-anaesthetized mice. , 1990, In Vivo.

[8]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[9]  S. Cole,et al.  Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine: effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  G. Thurston,et al.  Flavone acetic acid induces a coagulopathy in mice. , 1989, British Journal of Cancer.

[11]  J. Brown,et al.  Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. , 1989, Cancer research.

[12]  J. Denekamp,et al.  Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. , 1989, European journal of cancer & clinical oncology.

[13]  M. Trotter,et al.  Histological evidence for nonperfused vasculature in a murine tumor following hydralazine administration. , 1989, International journal of radiation oncology, biology, physics.

[14]  J. Gavin,et al.  Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. , 1989, Journal of the National Cancer Institute.

[15]  G. Adams,et al.  Induction of severe tumor hypoxia by modifiers of the oxygen affinity of hemoglobin. , 1989, International journal of radiation oncology, biology, physics.

[16]  P. Okunieff,et al.  Effects of hydralazine on in vivo tumor energy metabolism, hematopoietic radiation sensitivity, and cardiovascular parameters. , 1989, International journal of radiation oncology, biology, physics.

[17]  J. Brown,et al.  Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. , 1989, Radiation research.

[18]  J. Overgaard,et al.  Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. , 1989, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[19]  J. Double,et al.  Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. , 1989, Journal of the National Cancer Institute.

[20]  J. Overgaard,et al.  Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapy. , 1989, Biomedica biochimica acta.

[21]  D. Hirst,et al.  Cinnarizine and flunarizine as radiation sensitisers in two murine tumours. , 1988, British Journal of Cancer.

[22]  J. Brown,et al.  Mechanism of action of the selective tumor radiosensitizer nicotinamide. , 1988, International journal of radiation oncology, biology, physics.

[23]  J. Evelhoch,et al.  Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. , 1988, Cancer research.

[24]  G. Adams,et al.  Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. , 1988, British Journal of Cancer.

[25]  P. Okunieff,et al.  Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. , 1988, Journal of the National Cancer Institute.

[26]  P. Vaupel,et al.  Effect of Various Calcium Antagonists on Blood Flow and Red Blood Cell Flux in Malignant Tumors , 1988 .

[27]  R. Jirtle,et al.  Chemical modification of tumour blood flow. , 1988, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[28]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[29]  G. P. Smith,et al.  Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect. , 1988, Journal of the National Cancer Institute.

[30]  P. Vaupel,et al.  Effect of injectable or inhalational anesthetics and of neuroleptic, neuroleptanalgesic, and sedative agents on tumor blood flow. , 1988, Radiation research.

[31]  J. Overgaard,et al.  The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay. , 1988, Acta oncologica.

[32]  D. Kerr,et al.  Phase I and pharmacokinetic study of flavone acetic acid. , 1987, Cancer research.

[33]  G. P. Smith,et al.  Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. , 1987, European journal of cancer & clinical oncology.

[34]  D. Chaplin,et al.  The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain. , 1987, International journal of radiation oncology, biology, physics.

[35]  M. Horsman,et al.  Radiosensitization by nicotinamide in vivo: a greater enhancement of tumor damage compared to that of normal tissues. , 1987, Radiation research.

[36]  J. Double,et al.  Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). , 1987, British Journal of Cancer.

[37]  K. Paull,et al.  Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. , 1986, Cancer treatment reports.

[38]  H. Suit,et al.  Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/sed mouse to radiation. , 1985, Radiation research.

[39]  R. Pero,et al.  Radiosensitization effects of nicotinamide on malignant and normal mouse tissue. , 1985, Cancer Research.

[40]  B. Cullen,et al.  The effect of several different anaesthetics on the blood pressure and heart rate of the mouse and on the radiation response of the mouse sarcoma RIF-1. , 1985, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[41]  R. Jain,et al.  Tumor Blood Flow-Characterization, Modifications, and Role in Hyperthermia , 1984, IEEE Transactions on Sonics and Ultrasonics.

[42]  R. Pero,et al.  Nicotinamide as a radiosensitizer of a C3H mouse mammary adenocarcinoma. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[43]  W. Kaelin,et al.  Blood flow to primary tumors and lymph node metastases in SMT-2A tumor-bearing rats following intravenous flunarizine. , 1984, Cancer research.

[44]  C. Babbs,et al.  Abnormal response of tumor vasculature to vasoactive drugs. , 1984, Journal of the National Cancer Institute.

[45]  R. Hill,et al.  Effect of tumor blood flow manipulations on radiation response. , 1983, International journal of radiation oncology, biology, physics.

[46]  D. Hirst,et al.  Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. , 1983, Cancer research.

[47]  J. Denekamp,et al.  Vascular occlusion and tumour cell death. , 1983, European journal of cancer & clinical oncology.

[48]  D. Dewitt,et al.  Theoretical feasibility of vasodilator-enhanced local tumor heating. , 1982, European journal of cancer & clinical oncology.

[49]  C. Babbs,et al.  Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. , 1982, European journal of cancer & clinical oncology.

[50]  W. Kaelin,et al.  Effect of verapamil on malignant tissue blood flow in SMT-2A tumor-bearing rats. , 1982, Cancer research.

[51]  K. Hori,et al.  Selective increase in tumor oxygen tension with angiotensin II. , 1982, Invasion and Metastasis.

[52]  K. Hori,et al.  A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. , 1981, Journal of the National Cancer Institute.

[53]  J. Lekven,et al.  Effects of vasopressin, noradrenalin and oxytocin on blood flow distribution in rat kidney with neoplasm. , 1981, Acta radiologica. Oncology.

[54]  P. Sheldon,et al.  The effect of anesthetics on the radiosensitivity of a murine tumor. , 1979, Radiation research.

[55]  J. Denekamp,et al.  The effect of pentobarbital anaesthesia on the radiosensitivity of four mouse tumours. , 1979, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[56]  R. Jirtle,et al.  Effects of several vasoactive drugs on the vascular resistance of MT-W9B tumors in W/Fu rats. , 1978, Cancer research.

[57]  J. Fowler,et al.  Changes in mouse blood pressure, tumor blood flow, and core and tumor temperatures following nembutal or urethane anesthesia. , 1976, Radiology.

[58]  J. Fowler,et al.  The measurement of blood perfusion in experimental tumors by uptake of 86Rb. , 1974, Cancer research.

[59]  V. Popovic,et al.  Permanent cannulation of blood vessels in mice. , 1968, Journal of applied physiology.

[60]  J. Kruuv,et al.  Blood flow and oxygenation of tumors in mice. II. Effects of vasodilator drugs , 1967, Cancer.

[61]  N. Heatley,et al.  FASHIONING POLYETHYLENE TUBING FOR USE IN PHYSIOLOGICAL EXPERIMENTS. , 1964, Journal of applied physiology.

[62]  J. Weeks.  EXPERIMENTAL NARCOTIC ADDICTION. , 1964, Scientific American.

[63]  P. Gullino,et al.  Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors. , 1962, Journal of the National Cancer Institute.

[64]  J. A. Jones,et al.  Routine Direct Measurement of Arterial Pressure in Unanesthetized Rats , 1960, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[65]  L. Sapirstein,et al.  Regional blood flow by fractional distribution of indicators. , 1958, The American journal of physiology.